HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 577-588 of 1,811
Other study type icon
CompletedNCT00508677

Mazindol in Children With ADHD : Efficacy, Safety and Pharmacokinetic study

Official study title

Mazindol in Children With Attention Deficit Hyperactivity Disorder Design Study to Explore the Effectiveness, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Doses of Mazindol.

This study has finished and is no longer accepting participants.

In Paris
ADHDObservational studyAges 6–12
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Device study icon
CompletedNCT01968512

Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder

Official study title

Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder: Contribution of the Transcranial Direct Current Stimulation in Control Inhibitory.

This study has finished and is no longer accepting participants.

In Salvador
ADHDDevice studyAges 18–60
Countries
Brazil
Sponsor
Federal University of Bahia
Other study type icon
CompletedNCT00416091

Neuropsychological Functioning Among Children With Tourret's Disorder and ADHD

Official study title

Neuropsychological Functioning, Symptomatology, and Social Adjustment Among Children With Tourret's Disorder, Attention-Deficit/Hyperactivity Disorder, and Comorbid Conditions.

This study has finished and is no longer accepting participants.

In Taipei
ADHDObservational studyAges 8–16
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Drug study icon
CompletedNCT01338818

Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Official study title

A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in the Treatment of Adult Patients With Childhood-onset ADHD

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 18–60
Countries
United States, Belgium, Colombia, + 3 others
Sponsor
Novartis Pharmaceuticals
Drug study icon
CompletedNCT00772161

Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

A Single-Center, Single-Blind, Randomized, Oral Dose Cross-Over Study in Prepuberal Boys With ADHD to Investigate Efficacy and Bioequivalence of 20 mg Ritalin LA Compared to 20 mg Medikinet Retard After Treatment With o.d. Doses Over 7 Days Each.

This study has finished and is no longer accepting participants.

In Freiburg im Breisgau
ADHDMedication studyAges 8–14
Countries
Germany
Sponsor
University Hospital Freiburg
Drug study icon
CompletedNCT00556296

Study of NRP104 in Children Aged 6-12 With ADHD

What is this study about?

Researchers compared NRP104 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 6–12
Countries
Sponsor
New River Pharmaceuticals

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.